Dr Wise on the Impact of Genetic Testing on Patient Outcomes

David R. Wise, MD, PhD, discusses his presentation from an OncLive® State of the Science Summit™ on prostate cancer, during where he discussed the treatment of patients with metastatic castration-resistant prostate cancer.

Related Keywords

, Department Of Urology , Department Of Medicine , Langone Health Perlmutter Cancer Center , Grossman School Of Medicine , Langone Health , Genitourinary Medical Oncology , Perlmutter Cancer Center , Science Summit , Nyu Langone X27s Perlmutter Cancer Center , Onclive Tv , Prostate Cancer ,